NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Assets | ₹4,024 Cr | ₹3,000 Cr | ₹2,487 Cr | ₹2,345 Cr | ₹2,326 Cr |
What is the latest Total Current Assets ratio of NATCO PHARMA ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹4,024 Cr |
Mar2023 | ₹3,000 Cr |
Mar2022 | ₹2,487 Cr |
Mar2021 | ₹2,345 Cr |
Mar2020 | ₹2,326 Cr |
How is Total Current Assets of NATCO PHARMA Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹4,024 Cr | 34.10 | |
Mar2023 | ₹3,000 Cr | 20.65 | |
Mar2022 | ₹2,487 Cr | 6.05 | |
Mar2021 | ₹2,345 Cr | 0.83 | |
Mar2020 | ₹2,326 Cr | - |
Compare Total Current Assets of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,070.4 Cr | -5.4% | 2.3% | -17.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,778.0 Cr | 2.3% | 5.6% | 21.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,949.0 Cr | 1.5% | 4.2% | 51.2% | Stock Analytics | |
CIPLA | ₹123,222.0 Cr | 0% | 2.9% | 10% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,205.0 Cr | 0.6% | 0.9% | 23.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,707.7 Cr | 0.8% | 1.8% | -5.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -5.4% |
2.3% |
-17.5% |
SENSEX | 0.9% |
4.2% |
8.3% |
You may also like the below Video Courses